Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Ghko B 2026 Feb 04, 16:00

Why stock market is down: Dow DJIA slides, S&P 500 sinks, Nasdaq dips

Ghko B 2026 Feb 04, 16:00

Crypto Trend Insight 2026: XRP Price Movements and Market Analysis

Ghko B 2026 Feb 04, 16:00

AI stocks to watch: Why Broadcom (AVGO) stock, NVDA stock and AMD are down?

Ghko B 2026 Feb 03, 16:00

Best Retail Stocks to Buy: Amazon (AMZN) stock, WMT stock, Home Depot

Frances Wang 2026 Feb 03, 16:00

The rise and fall of gold prices: What’s going on with gold XAU/USD?

Frances Wang 2026 Feb 03, 16:00

Bitcoin (BTC/USD) today: Bitcoin price under 76K, could BTC keep falling?

Ghko B 2026 Feb 01, 16:00

ETF trading for beginners: What’s the best S&P 500 ETF to invest in 2026?

Ghko B 2026 Feb 01, 16:00

Solana price forecast: What will Solana (SOL/USD) be worth in 5 years?

Ghko B 2026 Feb 01, 16:00

Microsoft stock price prediction 2026: What is the target price for MSFT?

Frances Wang 2026 Feb 01, 16:00

Trending AI stock analysis: Why Sandisk (SNDK) stock continues to rise?

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

2.27

Spread (%)

0.6224 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

182324150272

Shares Outstanding

538480671

Earnings Date (Next)

1999-11-22

Div Yield

2026-03-06

Ex-Dividend Date

2026-02-13

Forward annual dividend rate

9.66

Forward annual dividend yield

0.0285

EPS

14.22

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Georgy Istigechev 2026 Feb 02, 16:00

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

Ghko B 2026 Jan 29, 16:00

CFD trading basics: Long position VS. short position, which is better?

Ghko B 2026 Jan 27, 16:00

What is a stochastic indicator: How to read the stochastic indicator?

Trustpilot